![Tom Burt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Burt
Directeur/Bestuurslid bij
Synthace Ltd.
Profiel
Thomas Henry Burt is currently a Director at Synthace Ltd., a Partner at Sofinnova Partners SAS, and a Member of the Association of Engineering Doctorates.
He previously worked as an Investment Director at Ares Life Sciences LP, an Investment Director at Novo Holdings Ltd., an Associate at Piper Sandler Ltd., and an Associate at Novo Principal Investments.
He also served as a Non-Executive Director at Redx Pharma Plc from 2020 to 2023 and as an Assistant Director at Peel Hunt LLP from 2015 to 2017.
Burt holds a graduate degree from the University of Birmingham and undergraduate and doctorate degrees from University College London.
Actieve functies van Tom Burt
| Bedrijven | Functie | Begin |
|---|---|---|
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01-06-2017 |
Synthace Ltd.
 Synthace Ltd. Packaged SoftwareTechnology Services Develops life sciences R&D cloud platform | Directeur/Bestuurslid | 12-11-2021 |
Association of Engineering Doctorates | Corporate Officer/Principal | - |
Eerdere bekende functies van Tom Burt
| Bedrijven | Functie | Einde |
|---|---|---|
| REDX PHARMA LIMITED | Directeur/Bestuurslid | 01-09-2023 |
Peel Hunt LLP
 Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 28-04-2017 |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements. | Private Equity Analist | 31-01-2013 |
Novo Holdings Ltd.
 Novo Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Chief Investment Officer | - |
Ares Life Sciences LP
 Ares Life Sciences LP Investment ManagersFinance Acts as Private Equity Fund | Chief Investment Officer | - |
Opleiding van Tom Burt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
85
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Piper Sandler Ltd.
 Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Finance |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ares Life Sciences LP
Ares Life Sciences LP Investment ManagersFinance Acts as Private Equity Fund | Finance |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements. | Finance |
Redx Pharma Plc
 Redx Pharma Plc BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing novel, small molecule and targeted medicines for fibrotic disease | Health Technology |
Peel Hunt LLP
Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
Novo Holdings Ltd.
Novo Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Develops life sciences R&D cloud platform | Technology Services |
Association of Engineering Doctorates |
